{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:51:10Z","timestamp":1792068670369,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amepre.2021.04.015","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T01:03:57Z","timestamp":1625101437000},"page":"636-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Time From HIV Infection to Diagnosis in the U.S., 2014\u20132018"],"prefix":"10.1016","volume":"61","author":[{"given":"Anne H.","family":"Peruski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Linley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"DiNenno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Satcher","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amepre.2021.04.015_bib0001","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2021.04.015_bib0002","unstructured":"What is Ending the HIV Epidemic in the U.S.? Office of Infectious Disease and HIV\/AIDS Policy, HHS. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview. Updated June 2, 2021. Accessed June 23, 2021."},{"issue":"47","key":"10.1016\/j.amepre.2021.04.015_bib0003","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm6647e1","article-title":"Vital signs: human immunodeficiency virus testing and diagnosis delays - United States","volume":"66","author":"Dailey","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.amepre.2021.04.015_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15585\/mmwr.mm6811e1","article-title":"Vital signs: HIV transmission along the continuum of care - United States, 2016","volume":"68","author":"Li","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.amepre.2021.04.015_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QAI.0000000000000589","article-title":"Brief report: time from infection with the human immunodeficiency virus to diagnosis, United States","volume":"69","author":"Hall","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.amepre.2021.04.015_bib0006","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1093\/cid\/ciz1178","article-title":"Estimates of the time from seroconversion to ART initiation among people newly diagnosed with HIV from 2006 to 2015, New York City","volume":"71","author":"Robertson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amepre.2021.04.015_bib0007","first-page":"1","article-title":"HIV testing and healthcare utilization among U.S. African-American women","volume":"29","author":"Dangerfield","year":"2018","journal-title":"J Natl Black Nurses Assoc"},{"issue":"3","key":"10.1016\/j.amepre.2021.04.015_bib0008","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1049732315616624","article-title":"Facilitators and barriers to HIV screening: a qualitative meta-synthesis","volume":"26","author":"Leblanc","year":"2016","journal-title":"Qual Health Res"},{"issue":"1","key":"10.1016\/j.amepre.2021.04.015_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciw666","article-title":"Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure","volume":"64","author":"Delaney","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amepre.2021.04.015_bib0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cir494","article-title":"Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 cells\/mm3: assessment of need following changes in treatment guidelines","volume":"53","author":"Lodi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amepre.2021.04.015_bib0011","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/cid\/cis1000","article-title":"Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts","volume":"56","author":"Touloumi","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amepre.2021.04.015_bib0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/QAI.0000000000001495","article-title":"Estimated HIV incidence, prevalence, and undiagnosed infections in U.S. states and Washington, DC, 2010-2014","volume":"76","author":"Satcher Johnson","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amepre.2021.04.015_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S1518-8787.2016050006310","article-title":"Estimation of HIV incidence in two Brazilian municipalities, 2013","volume":"50","author":"Szwarcwald","year":"2016","journal-title":"Rev Saude Publica"},{"issue":"7","key":"10.1016\/j.amepre.2021.04.015_bib0014","first-page":"1","article-title":"Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections","volume":"38","year":"1989","journal-title":"MMWR Suppl"},{"key":"10.1016\/j.amepre.2021.04.015_bib0015","series-title":"Laboratory testing for the diagnosis of HIV infection: updated recommendations","year":"2014"},{"key":"10.1016\/j.amepre.2021.04.015_bib0016","series-title":"Implementing HIV testing in nonclinical settings: a guide for HIV testing providers","year":"2016"},{"issue":"5","key":"10.1016\/j.amepre.2021.04.015_bib0017","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/003335490812300512","article-title":"Risk factor redistribution of the national HIV\/AIDS surveillance data: an alternative approach","volume":"123","author":"Harrison","year":"2008","journal-title":"Public Health Rep"},{"issue":"282","key":"10.1016\/j.amepre.2021.04.015_bib0018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.amepre.2021.04.015_bib0019","series-title":"Analysis of Survival Data","author":"Cox","year":"1984"},{"issue":"2","key":"10.1016\/j.amepre.2021.04.015_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B (Methodol)"},{"key":"10.1016\/j.amepre.2021.04.015_bib0021","unstructured":"HIV testing initiatives: New York knows. NYC Health.https:\/\/www1.nyc.gov\/site\/doh\/providers\/health-topics\/aids-hiv-new-york-knows.page. Accessed October 30, 2020."},{"key":"10.1016\/j.amepre.2021.04.015_bib0022","series-title":"Expanded testing initiative","year":"2020"},{"issue":"RR\u201314","key":"10.1016\/j.amepre.2021.04.015_bib0023","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amepre.2021.04.015_bib0024","series-title":"HIV testing trends in the United States; 2000-2011","year":"2013"},{"issue":"11","key":"10.1016\/j.amepre.2021.04.015_bib0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2105\/AJPH.2019.305273","article-title":"HIV testing, access to HIV-related services, and late-stage HIV diagnoses across U.S. states, 2013-2016","volume":"109","author":"Krueger","year":"2019","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.amepre.2021.04.015_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5539\/gjhs.v8n7p9","article-title":"Barriers to HIV testing among young men who have sex with men (MSM): experiences from Clark County, Nevada","volume":"8","author":"Pharr","year":"2015","journal-title":"Glob J Health Sci"},{"issue":"1","key":"10.1016\/j.amepre.2021.04.015_bib0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2012.01.022","article-title":"Rapid HIV screening: missed opportunities for HIV diagnosis and prevention","volume":"54","author":"Patel","year":"2012","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.amepre.2021.04.015_bib0028","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QAI.0000000000000807","article-title":"Using a multitest algorithm to improve the positive predictive value of rapid HIV testing and linkage to HIV care in nonclinical HIV test sites","volume":"71","author":"Delaney","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"25","key":"10.1016\/j.amepre.2021.04.015_bib0029","doi-asserted-by":"crossref","first-page":"561","DOI":"10.15585\/mmwr.mm6825a2","article-title":"HIV testing in 50 local jurisdictions accounting for the majority of new HIV diagnoses and seven states with disproportionate occurrence of HIV in rural areas, 2016-2017","volume":"68","author":"Pitasi","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2021.04.015_bib0030","series-title":"HIV in prisons, 2015 - statistical tables","author":"Maruschak","year":"2017"},{"issue":"suppl 5","key":"10.1016\/j.amepre.2021.04.015_bib0031","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","article-title":"Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United states, 2016-2019: perspectives on recent experience and lessons learned","volume":"222","author":"Lyss","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2021.04.015_bib0032","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drugalcdep.2016.05.024","article-title":"Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20\u2009U.S. cities, 2012","volume":"165","author":"Cooley","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"10.1016\/j.amepre.2021.04.015_bib0033","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1097\/QAD.0b013e32833ef6c4","article-title":"CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era","volume":"24","author":"Lodi","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.amepre.2021.04.015_bib0034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAI.0000000000001151","article-title":"Using CD4 data to estimate HIV incidence, prevalence, and percent of undiagnosed infections in the United States","volume":"74","author":"Song","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.amepre.2021.04.015_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/OLQ.0000000000000864","article-title":"The use of technology for sexually transmitted disease partner services in the United States: a structured review","volume":"45","author":"Kachur","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.amepre.2021.04.015_bib0036","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/QAI.0000000000001709","article-title":"HIV self-testing increases HIV testing frequency in high-risk men who have sex with men: a randomized controlled trial","volume":"78","author":"Katz","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2021.04.015_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00333549161310S101","article-title":"Routine screening for HIV infection in medical care settings: a decade of progress and next opportunities","volume":"131","author":"Sullivan","year":"2016","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.amepre.2021.04.015_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2011.03.023","article-title":"Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial","volume":"58","author":"Walensky","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.amepre.2021.04.015_bib0039","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721002737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721002737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:00:51Z","timestamp":1760083251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379721002737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0749379721002737"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2021.04.015","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time From HIV Infection to Diagnosis in the U.S., 2014\u20132018","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2021.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}